The Board of directors in their meeting held on Thursday, 29th May, 2025 has recommended final dividend of Rs. 3/- per share i.e. 30% on equity shares of the company for the financial year ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Riddhi Siddhi Gluco Biols approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with auditors (Batliboi & Purohit) issuing an unmodified opinion on both. A final dividend of Rs. 3 per share (30% on equity) has been recommended, subject to shareholder approval. On a standalone basis, revenue from operations dropped sharply to Rs. 9,137.99 lakhs from Rs. 22,094.02 lakhs in FY24 due to the paper division being classified as a discontinued operation, but profit after tax rose modestly to Rs. 9,411.91 lakhs (FY24: Rs. 9,222.94 lakhs) with EPS of Rs. 132.01. The Board also approved material related party transactions with Bluecraft Agro Private Limited worth up to Rs. 500 crores per annum for trade purchases/sales over 5 years and another Rs. 350 crores for investments, guarantees, or security in BAPL's borrowings. Both auditor reports carry an Emphasis of Matter on a Rs. 308 lakh contingent income tax liability and on impairment of discontinued paper division assets.
Dividend is modest and signals routine shareholder returns, while the steep revenue decline reflects the company's exit from its paper business rather than a core slowdown. The two large related party transactions with Bluecraft Agro (totalling up to Rs. 850 crores) and continued negative operating cash flow (Rs. -3,748 lakhs in FY25) are the key items shareholders should watch closely for corporate governance and liquidity implications.